The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
  • Hangzhou Asian Games
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
  • Hangzhou Asian Games
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    BTS' Jungkook to drop 2nd solo single

  • 3

    PHOTOSTrapped along borders

  • 5

    VIDEOBustling Chuseok: Namsan Hanok Village immerses visitors in Korea's rich traditions

  • 7

    Pentagon's CWMD strategy document calls N. Korea 'persistent threat'

  • 9

    Are 'finfluencers' helping or harming investment community?

  • 11

    Yoon hosts Chuseok luncheon for Korean atomic bomb victims in Hiroshima

  • 13

    Apple, China met to discuss Beijing's crackdown on western apps: WSJ

  • 15

    Poll shows 79% of young Koreans agree on need to improve ties with Japan

  • 17

    Second release of Fukushima wastewater to start next week

  • 19

    S. Korea cruises past N. Korea in women's basketball

  • 2

    Korea wins gold in League of Legends competition; Faker tops podium

  • 4

    Trailblazing nonagenarian artist honored for redefining Korean fiber art

  • 6

    Opposition leader Lee again proposes talks with President Yoon

  • 8

    BTS' Jungkook drops 2nd solo single

  • 10

    Builders vie for leadership in modular construction

  • 12

    Korea fails to be included on FTSE Russell's global bond index

  • 14

    Swimmer Kim Woo-min captures 3rd gold in Hangzhou

  • 16

    INTERVIEW'Coexistence of different art hubs across Asia is necessary': Art Week Tokyo Director

  • 18

    My left arm: how right-handed shooter won Asiad medal with left hand

  • 20

    S. Korea eliminates N. Korea in women's table tennis doubles

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
Bio
  • Tech
  • Bio
  • Companies
  • World Expo 2030
Sun, October 1, 2023 | 14:42
Samsung Biologics seeks to expand partnerships in New York
Samsung Biologics seeks to expand partnerships in New York
Samsung Biologics will take part in 2023 DCAT Week, a global event in the bio and pharmaceutical industry, which will take place in New York from March 20 to 23, in a bid to seek more partnerships, the company said Thursday. Hosted by the Drug, Chemical & Associated Technologies Association (DCAT), DCAT Week has been a representative networking event in the pharmaceutical ind...
Baek Byung-yeul | 2023-03-16 16:05
Celltrion founder to return to management after 2 year-hiatus
Celltrion founder to return to management after 2 year-hiatus
Seo Jung-jin, founder and honorary chairman of Celltrion, may return to management after two years, on expectations he can save the biotechnology group that is facing growing business uncertainties, according to company officials, Friday.
Baek Byung-yeul | 2023-03-03 16:52
Kakao Healthcare to launch blood sugar managing app in Q3
Kakao Healthcare to launch blood sugar managing app in Q3
Kakao Healthcare, a subsidiary of internet company Kakao, revealed a detailed vision for digital healthcare, saying it will launch a blood sugar management app in the third quarter of this year, according to the CEO, Thursday. “Digital healthcare has emerged as a lucrative business,” Hwang Hee, CEO of Kakao Healthcare, said during a press conference at Kakao's building in Seo...
Baek Byung-yeul | 2023-03-02 16:22
Samsung Biologics hit by series of attempts to steal trade secrets
Samsung Biologics hit by series of attempts to steal trade secrets
Samsung Biologics has been grappling with a series of attempts to steal its trade secrets as competition is intensifying in contract-based drug development and manufacturing, according to police and industry officials, Monday. Incheon Metropolitan Police said one of Samsung Biologics' employees was arrested recently for attempting to take company data from a worksite without ...
Baek Byung-yeul | 2023-02-27 16:56
Will Medytox's legal win over Daewoong deal blow to Hugel?
Will Medytox's legal win over Daewoong deal blow to Hugel?
Medytox's legal win over Daewoong Pharmaceutical is expected to shake up the local botulinum toxin (BTX) market, as Medytox, Korea's first Botox developer, is also embroiled in a legal tussle with another competitor, Hugel in the United States, over the BTX strain used to manufacture the cosmetics treatment, according to the companies, Monday. On Friday, the Seoul District Co...
Baek Byung-yeul | 2023-02-13 16:45
Medytox wins botulinum toxin patent suit against Daewoong
Medytox wins botulinum toxin patent suit against Daewoong
Medytox won a lawsuit against Daewoong Pharmaceutical on Friday over a botulinum toxin (BTX or Botox) patent. The two companies had locked horns over the origin of BTX strain used to manufacture the cosmetic treatment. “Daewoong Pharmaceutical's Nabota was developed by stealing Medytox's botulinum toxin strains and manufacturing process,” the Seoul Central District Court said...
Baek Byung-yeul | 2023-02-12 16:29
HLB's anticancer drug wins approval in China
HLB's anticancer drug wins approval in China
HLB's anticancer drug Rivoceranib was approved to be used for first-line treatment for liver cancer in China, the Korean biotech company said Thursday. The company said China's National Medical Products Administration (NMPA) approved the combination therapy of Rivoceranib and Camrelizumab, an anticancer drug of China's Jiangsu Hengrui Medicine, as a first-line treatment for l...
Baek Byung-yeul | 2023-02-02 16:44
SK Bioscience recruits experts for global expansion
SK Bioscience recruits experts for global expansion
SK Bioscience, developer of SKYCovione, Korea's first COVID-19 vaccine, has recruited renowned executives who have worked for global biopharmaceutical companies as part of its efforts to advance into the global market and diversify, according to the company, Friday. The company said it appointed Richard Kensinger as vice president of R&D project management at its U.S. branch,...
Baek Byung-yeul | 2023-01-20 14:40
Korea to invest $222.9 million in bio RD projects in 2023
Korea to invest $222.9 million in bio RD projects in 2023
Korea will extend 274.6 billion won ($222.9 million) for research and development in the bio industry this year, the industry ministry said Friday.
2023-01-20 10:35
S. Korea seeks to attract $500 mil. in investment from two European bio firms
S. Korea seeks to attract $500 mil. in investment from two European bio firms
South Korea's Industry Minister Lee Chang-yang met with top executives of Germany's Merck Life Science and Switzerland-based Novartis on Thursday in Davos, Switzerland, to discuss their potential investment in South Korea worth $500 million combined, his office said.
2023-01-19 20:22
123 4 5678910
Top 10 Stories
1[INTERVIEW] Risk-averse culture is forcing daring creators to flee showbiz INTERVIEWRisk-averse culture is forcing daring creators to flee showbiz
2Koreans adapt to soaring food prices Koreans adapt to soaring food prices
3[PHOTOS] Trapped along borders PHOTOSTrapped along borders
4Education ministry prohibits parents from recording classes Education ministry prohibits parents from recording classes
5[VIDEO] Bustling Chuseok: Namsan Hanok Village immerses visitors in Korea's rich traditions VIDEOBustling Chuseok: Namsan Hanok Village immerses visitors in Korea's rich traditions
6Value, consumer goods, financial stocks expected to gain momentum after Chuseok holiday Value, consumer goods, financial stocks expected to gain momentum after Chuseok holiday
7Are 'finfluencers' helping or harming investment community? Are 'finfluencers' helping or harming investment community?
8Builders vie for leadership in modular construction Builders vie for leadership in modular construction
9[INTERVIEW] ROK-US alliance is win-win partnership: KUSAF chief INTERVIEWROK-US alliance is win-win partnership: KUSAF chief
10Over 30,000 protesters march for climate actions Over 30,000 protesters march for climate actions
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group